HLF — Herbalife Nutrition Ltd.

Summary of Herbalife Limited Q3 2025 Earnings Call

1. Key Financial Results and Metrics

• Net Sales: $1.3 billion, up 2.7% year-over-year and above guidance midpoint. Constant currency sales increased by 3.2%.
• Adjusted EBITDA: $163 million, exceeding guidance of $150-$160 million. Adjusted EBITDA margin declined to 12.8% due to non-repeat of prior year’s government grant income and foreign exchange headwinds.
• Net Income: $43 million; adjusted net income of $52 million, with adjusted diluted EPS of $0.50, impacted by an $0.08 FX headwind.
• Cash Flow: Operating cash flows increased by 40% to $139 million. The company fully repaid its 2025 notes, reducing leverage to 2.8x.
• New Distributor Growth: North America saw a 17% increase in new distributors, although worldwide new distributor growth declined by 2%.

2. Strategic Updates and Business Highlights

• Return to Growth: Herbalife achieved net sales growth in North America for the first time since Q2 2021, driven by disciplined execution and foundational work.
• Product Innovations: Launched new products including Multiburn and HL/Skin, with strong early engagement metrics. The Pro2col app is in beta testing with over 7,900 distributors, showing high engagement.
• Technology Integration: The company is enhancing its digital capabilities with personalized health solutions and AI-driven features, aiming to deepen distributor engagement and customer interaction.
• Global Engagement: Hosted five Extravaganzas with 57,000 attendees, reflecting strong distributor engagement and community commitment.

3. Forward Guidance and Outlook

• Q4 2025 Guidance: Expected net sales growth of 1.5% to 5.5% year-over-year (including a 100 basis point currency tailwind). Adjusted EBITDA is projected between $144 million and $154 million.
• Full Year 2025 Outlook: Revised net sales guidance to a slight decline of 0.3% to growth of 0.7% year-over-year. Adjusted EBITDA is expected to range from $645 million to $655 million.
• Long-term Debt Reduction: Committed to reducing gross debt to $1.4 billion by the end of 2028, with a focus on cash generation and internal investments.

4. Bad News, Challenges, or Points of Concern

• Declining Metrics: Worldwide new distributor growth declined by 2%, although there was a notable 11% increase over a two-year stacked basis.
• Foreign Exchange Impact: FX movements negatively impacted both net sales and adjusted EBITDA, with a $6 million headwind noted in Q3.
• Increased Tax Rate: The adjusted effective tax rate rose to 32.7% from 22.3% year-over-year, affecting adjusted diluted EPS.

5. Notable Q&A Insights

• Capital Allocation: Management is focused on debt reduction and internal investments rather than stock buybacks at this time.
• Product Launch Costs: No significant increase in SG&A anticipated for new product education; existing distributor training formats are deemed sufficient.
• Pro2col Beta Feedback: Early responses indicate high engagement and valuable feedback from distributors, aiding in product refinement before broader market release.
• Growth in North America: The recent growth is attributed to renewed excitement and effective distributor engagement strategies, with expectations for sustained performance.

Overall, Herbalife's Q3 2025 results reflect a positive turnaround with growth in net sales and strategic advancements, despite some challenges related to currency impacts and distributor metrics. The company is optimistic about future growth driven by innovation and technology integration.